WALTHAM, Mass., April 4, 2025 /PRNewswire/ -- Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the "Company" or "Spyre"), a clinical-stage biotechnology company utilizing best-in-class antibody engineering, dose optimization and rational therapeutic combinations to target improved efficacy and...
Read More Details
Finally We wish PressBee provided you with enough information of ( Spyre Therapeutics Announces Grants of Inducement Awards )
Also on site :